CXO MovesLeadership & Strategy

Dr. Reddy's Laboratories appoints Devang Mehta as Category Head Marketing, GI Portfolio

By Ash Kate
Dr. Reddy's Laboratories appoints Devang Mehta as Category Head Marketing, GI Portfolio

Article content

Dr. Reddy's Laboratories has appointed Devang Mehta as Category Head Marketing for its GI portfolio, adding marketing leadership to the pharmaceutical company's work in this therapeutic area.

The appointment places Devang in a role focused on the marketing of medicines addressing gastrointestinal conditions, a category spanning treatments for a range of digestive health needs.

His new position comes within Dr. Reddy's broader pharmaceutical business, where portfolio marketing plays a role in connecting therapeutic offerings with healthcare professionals and patients.

Leading Marketing for the GI Portfolio

As Category Head Marketing, GI Portfolio, Devang will take on responsibility within a therapeutic category focused on gastrointestinal health.

Category marketing in pharmaceuticals involves understanding treatment needs, market dynamics and the healthcare professionals involved in prescribing and managing therapies. It also requires communicating product information in line with applicable medical, regulatory and industry requirements.

The role places marketing within the wider effort to support the reach and positioning of medicines in the GI category.

Marketing in a Changing Healthcare Landscape

Pharmaceutical marketing operates in an environment shaped by evolving treatment needs, clinical evidence, regulatory requirements and changing expectations across healthcare systems.

For gastrointestinal therapies, the breadth of conditions and treatment options makes clear communication and an understanding of the healthcare landscape important elements of category management.

Devang's new role will sit within this context as he takes on marketing responsibilities for Dr. Reddy's GI portfolio.

A New Chapter at Dr. Reddy's Laboratories

Devang announced his new position, marking the start of his next professional chapter at Dr. Reddy's Laboratories.

His appointment adds to the company's marketing organisation as it continues its work across pharmaceutical products and therapeutic categories.

Further details about his specific priorities and the scope of his responsibilities have not been publicly outlined in the announcement.


About Dr. Reddy's Laboratories

Dr. Reddy's Laboratories is a global pharmaceutical company headquartered in Hyderabad, India. The company develops, manufactures and markets pharmaceutical products across multiple therapeutic areas and markets worldwide.

Source and Credits: Devang Mehta's LinkedIn announcement